Companies /Healthcare

Cartesian Therapeutics Inc.

NASDAQ: RNAC Biotechnology

$7.24

▲ $0.03 (+0.42%) today

Markets closed · 5:10am ET

Fundamentals

Market Cap

$218.1M

Revenue (TTM)

$1.5M

EPS (TTM)

$-5.62

52-Week Range

$6 – $11

Street Target

$33.67

About Cartesian Therapeutics

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company is headquartered in Watertown, Massachusetts.

RNAC Coverage

3:59pm ET

Investing

Kyverna Therapeutics Sinks 13%: Here’s Why

A single analyst note sent Kyverna Therapeutics tumbling despite a clinical milestone that had investors cheering just weeks ago, and the question now is whether the selloff marks a buying opportunity or…

ALLO BEAM CABA

Danielle Liverance